Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07249281 | MR Microstructural Imaging for Prostate Cancer Diagnosis | recruiting | — | 2,000 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT05384535 | Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort | recruiting | N/A | 100 | Northwell HealthOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05739565 | Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients(ACTI-PAIR2) | recruiting | N/A | 850 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05965180 | Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe | recruiting | — | 50 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | recruiting | Phase 1 / Phase 2 | 39 | Institute of Cancer Research, United KingdomOTHER | 2 | Nov 24, 2025 | clinicaltrials |
| NCT07106827 | A Study of GV20-0251 in Advanced or Refractory Solid Tumors | recruiting | Phase 1 | 10 | West China HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07244393 | Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 | 30 | Cellbion Co., Ltd.INDUSTRY | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07245342 | Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy(EA) | not yet recruiting | N/A | 216 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07242014 | 68Ga-XACP3 PET/CT in Prostate Cancer | recruiting | N/A | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT02333435 | Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life(RCT-EPA) | active not recruiting | Phase 2 | 130 | CHU de Quebec-Universite LavalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07238959 | Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer | not yet recruiting | — | 1,100 | Shanghai Changzheng HospitalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07239518 | A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After Prostatectomy(PEACE) | not yet recruiting | N/A | 144 | Bin XuOTHER | 0 | Nov 20, 2025 | clinicaltrials |
| NCT07164794 | Memantine Hydrochloride in Prostate Cancer Patients | not yet recruiting | Phase 2 | 15 | Bin XuOTHER | 0 | Nov 19, 2025 | clinicaltrials |
| NCT03408964 | Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients | recruiting | — | 600 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT03912883 | Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting(TAPG) | active not recruiting | — | 3,350 | Queen Mary University of LondonOTHER | 0 | Nov 18, 2025 | clinicaltrials |
| NCT04543799 | Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer(SIESTA) | recruiting | — | 60 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05850182 | Lifestyle Intervention in Patients With Metastatic Prostate Cancer(ACTIDIET-PRO) | recruiting | N/A | 30 | Oncology Institute of Southern SwitzerlandOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06917781 | Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome(TAYLOR) | recruiting | N/A | 80 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07131956 | Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | recruiting | — | 200 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07163910 | Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study | recruiting | Phase 2 | 93 | baotai LiangOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07234097 | The Influence of Music on perceiVed paIn and leVels of Anxiety whiLe unDergoing transperIneal Prostate Biopsy: the VIVALDI Trial(VIVALDI) | not yet recruiting | N/A | 78 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 0 | Nov 18, 2025 | clinicaltrials |
| NCT02339701 | Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer | active not recruiting | N/A | 68 | Chinese University of Hong KongOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05973487 | A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors | active not recruiting | Phase 1 | 840 | TScan Therapeutics, Inc.INDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT06733337 | A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer. | active not recruiting | — | 1 | PfizerINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT07231159 | Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots | recruiting | — | 200 | AdventHealthOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT04115254 | Stereotactic Magnetic Resonance Guided Radiation Therapy | recruiting | N/A | 397 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT02735252 | PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer | active not recruiting | N/A | 156 | University of California, San FranciscoOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT03582475 | Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate | active not recruiting | Phase 1 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06536374 | Folate Study in Men With Advanced Prostate Cancer | not yet recruiting | Phase 2 | 50 | University of California, San DiegoOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06398639 | Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer(PRS) | recruiting | N/A | 1,500 | Adam S. Kibel, MDOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT03541850 | Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery | active not recruiting | Phase 2 | 92 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT04550845 | Understanding of Genetics by Men at Risk for Prostate Cancer | recruiting | N/A | 90 | Mayo ClinicOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT07071207 | Effect of Text Message Reminders on M-ISI Score After Prostate Surgery(TextMsgM-ISI) | recruiting | N/A | 132 | University of RochesterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT04349501 | Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)(ProsRSI) | active not recruiting | N/A | 100 | University of California, San DiegoOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06062745 | Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT | recruiting | Phase 1 | 30 | Brigham and Women's HospitalOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06479187 | PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer | active not recruiting | Phase 4 | 20 | Brigham and Women's HospitalOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06659614 | Prostate Tissue BioBank(PTBB) | recruiting | — | 200 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT05100472 | A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer | active not recruiting | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT07219303 | Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer(DE-CART) | recruiting | N/A | 80 | Fox Chase Cancer CenterOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT07222436 | Circulating Tumor DNA in High Risk Localized Prostate Cancer | recruiting | — | 24 | University of PittsburghOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT05779943 | Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer | active not recruiting | Phase 2 | 20 | Emory UniversityOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT01794403 | Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer(HEAT) | active not recruiting | N/A | 161 | University of MiamiOTHER | 3 | Oct 24, 2025 | clinicaltrials |
| NCT05919329 | Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy | recruiting | Phase 4 | 80 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT06165302 | Exercise in Prostate Cancer | recruiting | N/A | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT06141993 | ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials(ARCTIC) | recruiting | — | 120 | Duke UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT01514669 | Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer | active not recruiting | — | 75 | University of ArkansasOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT05540392 | An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues | active not recruiting | Phase 1 / Phase 2 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT05540782 | A Study of Cognitive Health in Survivors of Prostate Cancer | active not recruiting | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT02917798 | Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes | active not recruiting | — | 1,047 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 7, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Nov 25, 2025source: clinicaltrials